ASC Therapeutics Licenses Critical Technologies for Hemophilia A Gene Therapy from Expression Therapeutics - Yahoo Finance

ASC Therapeutics Licenses Critical Technologies for Hemophilia A Gene Therapy from Expression Therapeutics  Yahoo Finance

ASC Therapeutics, A Division of Applied StemCell, Inc. , announced today that it has obtained an exclusive therapeutics license from Expression Therapeutics, ...